Allogene Therapeutics, Inc. operates as a biotechnology company. The Company develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumor. "chimeric antigen receptor T (CAR-T) cells is said anti leukemia role, and can be used to treat or prevent relapse by targeting minimal residual disease for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). On May 13 2020 their stock chart value bearish $30.90. maybe because of this CORONA our pharmaceuticals focuses on developing COVID 19 kits but today their stock chart value is said hit $43.53 Anyone feel like it will potentially run more? Wanna Know more about BULLISH strategy READ MORE: